Access cutting-edge skin cancer treatment through this clinical trial at a research site in Irvine. Study-provided care at no cost to qualified participants.
Access skin cancer specialists in Irvine at no cost
This study follows strict safety protocols and ethical guidelines
All study-related skin cancer treatment provided free
This phase III trial compares the effect of adding cemiplimab to standard therapy (surgery with or without radiation) versus standard therapy alone in treating patients with stage III/IV squamous cell skin cancer that is able to be removed by surgery (resectable) and that may have come back after a period of improvement (recurrent). The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which uses hig
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this skin cancer clinical trial in Irvine, CA
If you're searching for skin cancer treatment options in Irvine, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Irvine research site is actively enrolling participants for this clinical trial. You'll receive care from experienced skin cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.